PhotoniCare, a startup located in EnterpriseWorks in the University of Illinois Research Park, announced through press release on August 6, 2019, that they received a Phase I SBIR Award from the National Institutes of Health’s National Institute of Deafness & Communications Disorders (NIDCD). The NIDCD focuses on supporting and researching biomedical and behavioral research and on research training in both normal and disordered processes of hearing, voice, language, and other senses.
According to the National Institutes of Health, the $225,000 Phase I SBIR Award is funding PhotoniCare’s TOMi Scope. Carle Foundation Hospital in Urbana, IL and Innolitics are partnering with PhotoniCare for this project.
“We are honored to receive additional funding from the NIDCD, who has long been supporting our efforts to solve the problem of frequent misdiagnosis of middle ear infections and the overuse of antibiotics and sugery in children that result,” said Ryan Shelton, PhotoniCare’s co-founder and CEO. “This project is really going to amplify the impact of the TOMi Scope, and I personally can’t wait to see the results.”
To see the full press release, click HERE.